Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Bristol-Myers Squibb

Executive Summary

Bruce Ross to president, BMS U.S. Pharmaceuticals Group, responsible for the Squibb U.S. Pharmaceutical businesses, Bristol-Myers Oncology Division, Mead Johnson Labs, and medical, marketing, business development and sales services function supporting the pharmaceutical businesses. He reports to Ray Egan, president BMS U.S. Pharmaceuticals, Mead Johnson Nutritionals, Squibb Diagnostics, and Managed Health Care Group. A 29-year veteran who started with Bristol Labs in 1971, Ross became president of Bristol-Myer's U.S. Pharmaceutical Group in 1987. Reporting to him is James Mauzey, who was named president of the BMS U.S. Pharmaceutical Division. Mauzey joined the firm in 1989 from Lederle and most recently had been president of the Squibb U.S. Pharmaceutical Group.
UsernamePublicRestriction

Register

PS018309

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel